NM_014324.6:c.353G>C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_014324.6(AMACR):​c.353G>C​(p.Arg118Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R118Q) has been classified as Benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

AMACR
NM_014324.6 missense

Scores

1
18

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.50

Publications

0 publications found
Variant links:
Genes affected
AMACR (HGNC:451): (alpha-methylacyl-CoA racemase) This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene. [provided by RefSeq, Mar 2011]
C1QTNF3-AMACR (HGNC:49198): (C1QTNF3-AMACR readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring C1q and tumor necrosis factor related protein 3 (C1QTNF3) and alpha-methylacyl-CoA racemase (AMACR) genes on chromosome 5. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus not likely to produce a protein product. [provided by RefSeq, Mar 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12071863).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AMACRNM_014324.6 linkc.353G>C p.Arg118Pro missense_variant Exon 2 of 5 ENST00000335606.11 NP_055139.4 Q9UHK6-1
AMACRNM_001167595.2 linkc.353G>C p.Arg118Pro missense_variant Exon 2 of 6 NP_001161067.1 Q9UHK6-5
AMACRNM_203382.3 linkc.353G>C p.Arg118Pro missense_variant Exon 2 of 4 NP_976316.1 Q9UHK6-4
C1QTNF3-AMACRNR_037951.1 linkn.870G>C non_coding_transcript_exon_variant Exon 7 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AMACRENST00000335606.11 linkc.353G>C p.Arg118Pro missense_variant Exon 2 of 5 1 NM_014324.6 ENSP00000334424.6 Q9UHK6-1
ENSG00000289791ENST00000426255.6 linkc.353G>C p.Arg118Pro missense_variant Exon 2 of 5 2 ENSP00000476965.1 V9GYP4
C1QTNF3-AMACRENST00000382079.3 linkn.795G>C non_coding_transcript_exon_variant Exon 7 of 9 2 ENSP00000371511.3 E9PGA6

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000205
AC:
3
AN:
1461864
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
2
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53398
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000270
AC:
3
AN:
1112012
Other (OTH)
AF:
0.00
AC:
0
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
6.0
DANN
Benign
0.90
DEOGEN2
Benign
0.060
T;.;.;.;T;T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.044
N
LIST_S2
Uncertain
0.93
D;D;D;D;D;D;D
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.12
T;T;T;T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.42
N;N;N;.;.;.;.
PhyloP100
-1.5
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-1.6
N;N;N;N;.;.;.
REVEL
Benign
0.084
Sift
Benign
0.30
T;T;T;T;.;.;.
Sift4G
Benign
0.38
T;T;T;T;T;T;T
Polyphen
0.0
B;B;.;B;.;.;.
Vest4
0.37
MutPred
0.49
Gain of glycosylation at S113 (P = 0.0805);Gain of glycosylation at S113 (P = 0.0805);Gain of glycosylation at S113 (P = 0.0805);Gain of glycosylation at S113 (P = 0.0805);Gain of glycosylation at S113 (P = 0.0805);Gain of glycosylation at S113 (P = 0.0805);Gain of glycosylation at S113 (P = 0.0805);
MVP
0.33
MPC
0.073
ClinPred
0.057
T
GERP RS
-3.5
Varity_R
0.25
gMVP
0.76
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16892150; hg19: chr5-34005899; API